Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034060

Chief Legal Officer gave up 9,534 shares (to pay taxes)

  • Chief Legal Officer acquired 33,188 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ali-Jackson Kamil Chief Legal Officer 2020-06-01 Option exercise +33,188 132,387 D
Ali-Jackson Kamil Chief Legal Officer 2020-06-01 Shares withheld for taxes −9,534 $1.32 $12,585 122,853 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2020-06-01 Option exercise · Restricted stock units −33,188 33,189 D
Loading xslF345X03/doc4.xml…